Cantor Fitzgerald Upgrades Supernus Pharmaceuticals (SUPN) to Overweight
Tweet Send to a Friend
(Updated - July 30, 2025 6:55 AM EDT)Cantor Fitzgerald analyst Kristen Kluska upgraded Supernus Pharmaceuticals (NASDAQ: SUPN) from Neutral to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
